Skip to main content
Top
Published in: BMC Gastroenterology 1/2016

Open Access 01-12-2016 | Research article

Implications and issues related to familial pancreatic cancer: a cohort study of hospitalized patients

Authors: Martina Mughetti, Lucia Calculli, Anna Maria Chiesa, Federica Ciccarese, Odeta Rrusho, Raffaele Pezzilli

Published in: BMC Gastroenterology | Issue 1/2016

Login to get access

Abstract

Background

The surveillance of subjects at risk of pancreatic cancer is restricted to clinical research; the incidence of familial pancreatic cancer needs to be better established. Thus, we aimed to evaluate the frequency of familial pancreatic cancer in a population of hospitalized patients with pancreatic cancer.

Methods

A retrospective study based on the hospital charts of patients discharged with a diagnosis of pancreatic cancer. One hundred and eighty-seven patients or their relatives were called for a phone interview.

Results

There were 97 males (51.9 %) and 90 (48.1 %) females. The overall mean ± SD age was 67.3 ± 11.8 years; the age of males was similar to that of females (P = 0140). The mean size of the tumors found was 36.3 ± 17.4 mm (range of 5–110 mm); it was related to gender but was not related to the site of the tumor or the age of the patient. Regarding genetic diseases, three females (1.6 %) had familial adenomatous polyposis; three patients (1 male and two females) (1.6 %) had at least one relative with pancreatic cancer whereas only one 80-year old male patient (0.5 %) had two relatives affected by pancreatic cancer (the mother had died at the 65 years of age and the brother had died at 75 years of age).

Conclusions

The frequency of familial pancreatic ductal adenocarcinoma is small, but its importance, from the point of view of early diagnosis, is not negligible and patients with a risk of familial cancer merit an appropriate clinical follow-up.
Literature
3.
go back to reference Khawja SN, Mohammed S, Silberfein EJ, Musher BL, Fisher WE, Van Buren G, et al. Pancreatic cancer disparities in African Americans. Pancreas. 2015;44(4):522–7.PubMedCrossRef Khawja SN, Mohammed S, Silberfein EJ, Musher BL, Fisher WE, Van Buren G, et al. Pancreatic cancer disparities in African Americans. Pancreas. 2015;44(4):522–7.PubMedCrossRef
4.
go back to reference Del Chiaro M, Verbeke CS, Kartalis N, Pozzi Mucelli R, Gustafsson P, Hansson J, et al. Short-term results of a magnetic resonance imaging-based swedish screening program for individuals at risk for pancreatic cancer. JAMA Surg. 2015;150(6):512–8.PubMedCrossRef Del Chiaro M, Verbeke CS, Kartalis N, Pozzi Mucelli R, Gustafsson P, Hansson J, et al. Short-term results of a magnetic resonance imaging-based swedish screening program for individuals at risk for pancreatic cancer. JAMA Surg. 2015;150(6):512–8.PubMedCrossRef
5.
go back to reference Iskandar ME, Wayne MG, Steele JG, Cooperman AM. Familial pancreatic cancer: the case for prophylactic pancreatectomy in lieu of serial screening and shared decision making. Case Rep Oncol Med. 2014;2014:737183.PubMedPubMedCentral Iskandar ME, Wayne MG, Steele JG, Cooperman AM. Familial pancreatic cancer: the case for prophylactic pancreatectomy in lieu of serial screening and shared decision making. Case Rep Oncol Med. 2014;2014:737183.PubMedPubMedCentral
6.
go back to reference Del Chiaro M, Segersvärd R, Lohr M, Verbeke C. Early detection and prevention of pancreatic cancer: is it really possible today? World J Gastroenterol. 2014;20:12118–31.PubMedPubMedCentralCrossRef Del Chiaro M, Segersvärd R, Lohr M, Verbeke C. Early detection and prevention of pancreatic cancer: is it really possible today? World J Gastroenterol. 2014;20:12118–31.PubMedPubMedCentralCrossRef
7.
go back to reference Mohammed S, Van Buren 2nd G, Fisher WE. Pancreatic cancer: advances in treatment. World J Gastroenterol. 2014;20:9354–60.PubMedPubMedCentral Mohammed S, Van Buren 2nd G, Fisher WE. Pancreatic cancer: advances in treatment. World J Gastroenterol. 2014;20:9354–60.PubMedPubMedCentral
8.
go back to reference Rosato V, Polesel J, Bosetti C, Serraino D, Negri E, La Vecchia C. Population attributable risk for pancreatic cancer in Northern Italy. Pancreas. 2015;44:216–20.PubMedCrossRef Rosato V, Polesel J, Bosetti C, Serraino D, Negri E, La Vecchia C. Population attributable risk for pancreatic cancer in Northern Italy. Pancreas. 2015;44:216–20.PubMedCrossRef
10.
11.
go back to reference WHO. Obesity: Preventing and managing the global epidemic. WHO Technical Report Series 894 Geneva 2000. WHO. Obesity: Preventing and managing the global epidemic. WHO Technical Report Series 894 Geneva 2000.
12.
go back to reference Del Chiaro M, Zerbi A, Falconi M, Bertacca L, Polese M, Sartori N, et al. Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma. Pancreatology. 2007;7:459–69.PubMedCrossRef Del Chiaro M, Zerbi A, Falconi M, Bertacca L, Polese M, Sartori N, et al. Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma. Pancreatology. 2007;7:459–69.PubMedCrossRef
13.
go back to reference Del Chiaro M, Zerbi A, Capurso G, Zamboni G, Maisonneuve P, Presciuttini S, et al. Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry. Dig Liver Dis. 2010;42:597–605.PubMedCrossRef Del Chiaro M, Zerbi A, Capurso G, Zamboni G, Maisonneuve P, Presciuttini S, et al. Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry. Dig Liver Dis. 2010;42:597–605.PubMedCrossRef
14.
go back to reference Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62:339–47.PubMedPubMedCentralCrossRef Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62:339–47.PubMedPubMedCentralCrossRef
15.
go back to reference Mocci E, Guillen-Ponce C, Earl J, Marquez M, Solera J, Salazar-López MT, et al. PanGen-Fam: Spanish registry of hereditary pancreatic cancer. Eur J Cancer. 2015;51:1911–7.PubMedCrossRef Mocci E, Guillen-Ponce C, Earl J, Marquez M, Solera J, Salazar-López MT, et al. PanGen-Fam: Spanish registry of hereditary pancreatic cancer. Eur J Cancer. 2015;51:1911–7.PubMedCrossRef
16.
go back to reference Chen T, Fallah M, Kharazmi E, Ji J, Sundquist K, Hemminki K. Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database. J Invest Dermatol. 2014;134:930–6.PubMedCrossRef Chen T, Fallah M, Kharazmi E, Ji J, Sundquist K, Hemminki K. Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database. J Invest Dermatol. 2014;134:930–6.PubMedCrossRef
18.
go back to reference Pezzilli R, Morselli-Labate AM. Selecting families eligible for pancreatic cancer screening: another brick in the wall for the early detection of pancreatic ductal adenocarcinoma and its precursors. Dig Liver Dis. 2012;44:539–40.PubMedCrossRef Pezzilli R, Morselli-Labate AM. Selecting families eligible for pancreatic cancer screening: another brick in the wall for the early detection of pancreatic ductal adenocarcinoma and its precursors. Dig Liver Dis. 2012;44:539–40.PubMedCrossRef
19.
go back to reference Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223–62.PubMedPubMedCentralCrossRef Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223–62.PubMedPubMedCentralCrossRef
20.
go back to reference Zhen DB, Rabe KG, Gallinger S, Syngal S, Schwartz AG, Goggins MG, et al. BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med. 2015;17:569–77.PubMedCrossRef Zhen DB, Rabe KG, Gallinger S, Syngal S, Schwartz AG, Goggins MG, et al. BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med. 2015;17:569–77.PubMedCrossRef
21.
go back to reference Grant RC, Selander I, Connor AA, Selvarajah S, Borgida A, Briollais L, et al. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. Gastroenterology. 2015;148:556–64.PubMedCrossRef Grant RC, Selander I, Connor AA, Selvarajah S, Borgida A, Briollais L, et al. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. Gastroenterology. 2015;148:556–64.PubMedCrossRef
22.
go back to reference Gullo L, Pezzilli R, Morselli-Labate AM. Coffee and cancer of the pancreas: an Italian multicenter study. Pancreas. 1995;11:223–9.PubMedCrossRef Gullo L, Pezzilli R, Morselli-Labate AM. Coffee and cancer of the pancreas: an Italian multicenter study. Pancreas. 1995;11:223–9.PubMedCrossRef
23.
go back to reference Di Ciaula A, Portincasa P. Fat, epigenome and pancreatic diseases. Interplay and common pathways from a toxic and obesogenic environment. Eur J Intern Me. 2014;25:865–73.CrossRef Di Ciaula A, Portincasa P. Fat, epigenome and pancreatic diseases. Interplay and common pathways from a toxic and obesogenic environment. Eur J Intern Me. 2014;25:865–73.CrossRef
24.
go back to reference Pezzilli R, Morselli-Labate AM, Migliori M, Manca M, Bastagli L, Gullo L. Obesity and the risk of pancreatic cancer: an italian multicenter study. Pancreas. 2005;31:221–4.PubMedCrossRef Pezzilli R, Morselli-Labate AM, Migliori M, Manca M, Bastagli L, Gullo L. Obesity and the risk of pancreatic cancer: an italian multicenter study. Pancreas. 2005;31:221–4.PubMedCrossRef
25.
go back to reference Gullo L, Pezzilli R, Morselli-Labate AM. Diabetes and the risk of pancreatic cancer. N Engl J Med. 1994;331:81–4.PubMedCrossRef Gullo L, Pezzilli R, Morselli-Labate AM. Diabetes and the risk of pancreatic cancer. N Engl J Med. 1994;331:81–4.PubMedCrossRef
26.
go back to reference Pezzilli R. Pancreatic ductal carcinoma: from the bench to the bedside. J Pancreas. 2006;7:508–10. Pezzilli R. Pancreatic ductal carcinoma: from the bench to the bedside. J Pancreas. 2006;7:508–10.
27.
go back to reference Pezzilli R, Calculli L. Branch-type intraductal papillary mucinous neoplasm of the pancreas: clinically and patient-reported outcomes. Pancreas. 2015;44:221–6.PubMedCrossRef Pezzilli R, Calculli L. Branch-type intraductal papillary mucinous neoplasm of the pancreas: clinically and patient-reported outcomes. Pancreas. 2015;44:221–6.PubMedCrossRef
28.
go back to reference Buscarini E, Pezzilli R, Cannizzaro R, et al. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis. 2014;46:479–93.PubMedCrossRef Buscarini E, Pezzilli R, Cannizzaro R, et al. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis. 2014;46:479–93.PubMedCrossRef
30.
go back to reference Wang W, Chen S, Brune KA, Hruban RH, Parmigiani G, Klein AP. PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol. 2007;25:1417–22.PubMedPubMedCentralCrossRef Wang W, Chen S, Brune KA, Hruban RH, Parmigiani G, Klein AP. PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol. 2007;25:1417–22.PubMedPubMedCentralCrossRef
31.
go back to reference Friedlin J, McDonald CJ. Using a natural language processing system to extract and code family history data from admission reports. AMIA Annu Symp Proc 2006:925. Friedlin J, McDonald CJ. Using a natural language processing system to extract and code family history data from admission reports. AMIA Annu Symp Proc 2006:925.
32.
go back to reference Mehrabi S, Krishnan A, Roch AM, Schmidt H, Li D, Kesterson J, et al. Identification of patients with family history of pancreatic cancer - Investigation of an NLP System Portability. Stud Health Technol Inform. 2015;216:604–8.PubMed Mehrabi S, Krishnan A, Roch AM, Schmidt H, Li D, Kesterson J, et al. Identification of patients with family history of pancreatic cancer - Investigation of an NLP System Portability. Stud Health Technol Inform. 2015;216:604–8.PubMed
33.
go back to reference Rulyak SJ, Kimmey MB, Veenstra DL, Brentnall TA. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc. 2003;57:23–9.PubMedCrossRef Rulyak SJ, Kimmey MB, Veenstra DL, Brentnall TA. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc. 2003;57:23–9.PubMedCrossRef
Metadata
Title
Implications and issues related to familial pancreatic cancer: a cohort study of hospitalized patients
Authors
Martina Mughetti
Lucia Calculli
Anna Maria Chiesa
Federica Ciccarese
Odeta Rrusho
Raffaele Pezzilli
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2016
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-016-0421-8

Other articles of this Issue 1/2016

BMC Gastroenterology 1/2016 Go to the issue